Thera (THTX) Revenue & Revenue Breakdown
Thera Revenue Highlights
Latest Revenue (Y)
$81.76M
Latest Revenue (Q)
$16.09M
Main Segment (Y)
EGRIFTA
Main Geography (Y)
UNITED STATES
Thera Revenue by Period
Thera Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-11-30 | $81.76M | 2.13% |
| 2022-11-30 | $80.06M | 14.66% |
| 2021-11-30 | $69.82M | 5.71% |
| 2020-11-30 | $66.05M | 4.49% |
| 2019-11-30 | $63.22M | 39.81% |
| 2018-11-30 | $45.22M | 36.09% |
| 2017-11-30 | $33.23M | 20.36% |
| 2016-11-30 | $27.60M | 22.41% |
| 2015-11-30 | $22.55M | 282.22% |
| 2014-11-30 | $5.90M | -17.27% |
| 2013-11-30 | $7.13M | -47.78% |
| 2012-11-30 | $13.66M | -5.53% |
| 2011-11-30 | $14.46M | -53.75% |
| 2010-11-30 | $31.26M | 89.27% |
| 2009-11-30 | $16.52M | 676.60% |
| 2008-11-30 | $2.13M | -32.11% |
| 2007-11-30 | $3.13M | - |
Thera generated $81.76M in revenue during NA 2023, up 2.13% compared to the previous quarter, and up 180.83% compared to the same period a year ago.
Thera Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-02-29 | $16.09M | -31.41% |
| 2023-11-30 | $23.45M | 12.45% |
| 2023-08-31 | $20.86M | 18.84% |
| 2023-05-31 | $17.55M | -11.85% |
| 2023-02-28 | $19.91M | -7.06% |
| 2022-11-30 | $21.42M | 2.93% |
| 2022-08-31 | $20.81M | 8.01% |
| 2022-05-31 | $19.27M | 3.83% |
| 2022-02-28 | $18.56M | -1.05% |
| 2021-11-30 | $18.75M | 5.05% |
| 2021-08-31 | $17.85M | 0.37% |
| 2021-05-31 | $17.79M | 15.28% |
| 2021-02-28 | $15.43M | -19.31% |
| 2020-11-30 | $19.12M | 36.12% |
| 2020-08-31 | $14.05M | -18.14% |
| 2020-05-31 | $17.16M | 9.18% |
| 2020-02-29 | $15.72M | -4.15% |
| 2019-11-30 | $16.40M | 1.79% |
| 2019-08-31 | $16.11M | 3.22% |
| 2019-05-31 | $15.61M | 3.40% |
| 2019-02-28 | $15.10M | 7.96% |
| 2018-11-30 | $13.98M | 3.40% |
| 2018-08-31 | $13.52M | 40.89% |
| 2018-05-31 | $9.60M | 18.30% |
| 2018-02-28 | $8.11M | -16.90% |
| 2017-11-30 | $9.76M | 8.69% |
| 2017-08-31 | $8.98M | 21.14% |
| 2017-05-31 | $7.42M | 9.00% |
| 2017-02-28 | $6.80M | -11.96% |
| 2016-11-30 | $7.73M | 13.55% |
| 2016-08-31 | $6.80M | -1.27% |
| 2016-05-31 | $6.89M | 6.83% |
| 2016-02-29 | $6.45M | -2.03% |
| 2015-11-30 | $6.59M | -5.14% |
| 2015-08-31 | $6.94M | 18.52% |
| 2015-05-31 | $5.86M | 60.34% |
| 2015-02-28 | $3.65M | 71.11% |
| 2014-11-30 | $2.14M | 57938.38% |
| 2014-08-31 | $3.68K | -99.83% |
| 2014-05-31 | $2.21M | 46.76% |
| 2014-02-28 | $1.50M | 32.81% |
| 2013-11-30 | $1.13M | -45.21% |
| 2013-08-31 | $2.07M | -8.69% |
| 2013-05-31 | $2.26M | 28.70% |
| 2013-02-28 | $1.76M | -55.20% |
| 2012-11-30 | $3.92M | 1.91% |
| 2012-08-31 | $3.85M | 49.32% |
| 2012-05-31 | $2.58M | -19.67% |
| 2012-02-29 | $3.21M | -13.58% |
| 2011-11-30 | $3.71M | 3.34% |
| 2011-08-31 | $3.59M | 0.76% |
| 2011-05-31 | $3.57M | -0.88% |
| 2011-02-28 | $3.60M | -86.37% |
| 2010-11-30 | $26.40M | 1530.45% |
| 2010-08-31 | $1.62M | -0.50% |
| 2010-05-31 | $1.63M | -0.38% |
| 2010-02-28 | $1.63M | -23.48% |
| 2009-11-30 | $2.13M | -81.44% |
| 2009-08-31 | $11.51M | 630.38% |
| 2009-05-31 | $1.58M | 39.65% |
| 2009-02-28 | $1.13M | 411.92% |
| 2008-11-30 | $220.34K | -67.03% |
| 2008-08-31 | $668.36K | -6.53% |
| 2008-05-31 | $715.08K | 17.00% |
| 2008-02-29 | $611.16K | -56.05% |
| 2007-11-30 | $1.39M | - |
Thera generated $16.09M in revenue during Q1 2024, up -31.41% compared to the previous quarter, and up 75.09% compared to the same period a year ago.
Thera Revenue Breakdown
Thera Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Nov 23 | Nov 22 | Nov 21 | Nov 20 | Nov 19 |
|---|---|---|---|---|---|
| Trogarzo Net Sales | $28.06M | $29.60M | $26.81M | $30.65M | $27.70M |
| EGRIFTA | $53.70M | $50.45M | $43.01M | $35.40M | $35.52M |
Latest
Thera's latest annual revenue breakdown by segment (product or service), as of Nov 23: EGRIFTA (65.68%), and Trogarzo Net Sales (34.32%).
Thera Revenue Breakdown by Country
Annual Revenue by Country
| Country | Nov 23 | Nov 22 | Nov 21 | Nov 20 | Nov 19 |
|---|---|---|---|---|---|
| UNITED STATES | $81.39M | $78.74M | $68.10M | $65.45M | $62.92M |
| Europe | $286.00K | - | - | - | - |
| CANADA | $86.00K | $52.00K | $269.00K | $354.00K | $295.00K |
Latest
Thera's latest annual revenue breakdown by geography, as of Nov 23: UNITED STATES (99.55%), Europe (0.35%), and CANADA (0.11%).
Thera Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| THTX | Thera | $81.76M | $16.09M |
| GNFT | Genfit | $28.57M | $17.08M |
| IVA | Inventiva | $17.50M | $15.58M |
| TARS | Tarsus Pharmaceuticals | $17.45M | $48.12M |
| APLT | Applied Therapeutics | $9.99M | $144.00K |
| CNTA | Centessa Pharmaceuticals | $6.88M | - |
| VRCA | Verrica Pharmaceuticals | $5.12M | $-1.86M |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| LYRA | Lyra Therapeutics | $1.56M | $195.00K |
| MNOV | MediciNova | $1.00M | - |
| OPT | Opthea | $108.41K | $61.27K |
| LIAN | LianBio | - | - |
| NUVL | Nuvalent | - | - |
| BCAB | BioAtla | - | $11.00M |
| PHVS | Pharvaris | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| VIGL | Vigil Neuroscience | - | - |
| VINC | Vincerx Pharma | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| PEPG | PepGen | - | - |